ALTIMMUNE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ALTIMMUNE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 3.00K shares, a 2.85% increase year-over-year.
- ALTIMMUNE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 4.46K shares, a 256.64% increase year-over-year.
- ALTIMMUNE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- ALTIMMUNE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 10.00K shares, a 80.98% decline year-over-year.
- ALTIMMUNE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 14.17K shares, a 89.76% decline from fiscal 2024.
- ALTIMMUNE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 138.39K shares, a 474.81% increase from fiscal 2023.
- ALTIMMUNE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 24.07K shares, a 93.55% decline from fiscal 2022.
- ALTIMMUNE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 373.55K shares, a 590.88% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 3.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | 17.46K shares derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | 4.46K shares 10-Q · filed 2026-05-13 | 17.38K shares derived: sum of 4 quarters · filed 2026-05-13 |
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | 14.17K shares 10-K · filed 2026-03-06 |
| 2025-09-30 | 10.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 34.29K shares derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-06-30 | 2.92K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | 76.87K shares derived: sum of 4 quarters · filed 2025-08-12 |
| 2025-03-31 | 1.25K shares 10-Q · filed 2025-05-13 | 138.39K shares derived: sum of 4 quarters · filed 2025-05-13 |
| 2024-12-31 | 20.12K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 138.39K shares 10-K · filed 2025-02-27 |
| 2024-09-30 | 52.58K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | |
| 2024-06-30 | 64.43K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | |
| 2024-03-31 | 1.25K shares 10-Q · filed 2024-05-09 | |
| 2023-12-31 | 24.07K shares 10-K · filed 2024-03-27 | |
| 2022-12-31 | 373.55K shares 10-K · filed 2023-02-28 | |
| 2021-12-31 | 54.07K shares 10-K · filed 2022-03-15 | |
| 2020-12-31 | 46.97K shares 10-K · filed 2021-02-25 | |
| 2018-12-31 | -9.98K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | 9.54K shares 10-K · filed 2019-04-01 |
| 2018-09-30 | -683.22K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | |
| 2018-06-30 | -72.66K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | |
| 2018-03-31 | 775.39K shares 10-Q · filed 2018-05-15 | |
| 2017-12-31 | 200.86K shares 10-K · filed 2018-04-02 | |
| 2017-03-31 | 184.74K shares 10-Q · filed 2017-05-03 | |
| 2016-09-30 | 831.19K shares 10-Q · filed 2016-11-04 | |
| 2016-06-30 | 341.12K shares 10-Q · filed 2016-08-04 | |
| 2016-03-31 | 16.90K shares 10-Q · filed 2016-05-09 | |
| 2012-12-31 | 31.47K shares 10-K · filed 2013-03-14 | |
| 2011-12-31 | 44.46K shares 10-K · filed 2013-03-14 | |
| 2010-12-31 | 22.32K shares 10-K · filed 2013-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |